SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Elan Corporation, plc (ELN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
10345 171 0 ELN
Emcee:  Harold Engstrom Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9945Just listened to K Martin on the "Hidden Gems" conference of today. I fred hayes-10/13/2008
9944PML observed in a Raptiva (anti-CD11a) patient...... Genentech Issues Dear Healscaram(o)uche-10/2/2008
9943Re: MS drugs in phase-2 or phase-3 This Forbes write-up gives some color on theDewDiligence_on_SI-9/23/2008
9942Biogen put out an PR biogenidec.com "Patients on TYSABRI therapy have contiLee39-9/22/2008
9941Today from Irish stockbroker Goodbody's. Looks like they think T sales stillfred hayes-9/22/2008
9940And there was also the report today that one of the T patients with PML was imprBiotech Jim-9/19/2008
9939TYSABRI(R) Demonstrates Sustained Improvement in Functional Outcomes in Multiplescaram(o)uche-9/19/2008
9938Elan just started a new trial clinicaltrials.gov Good luck and <b>God<georgejjl1-9/13/2008
9937Everyone at Elan should be very proud of what Tysabri has done youtube.com Googeorgejjl1-9/13/2008
9936Genentech informed healthcare professionals of revisions to prescribing informatrkrw-9/11/2008
9935US FDA lists drugs under safety probes 09/05 01:13 PM WASHINGTON, Sept 5 Qualified Opinion-9/5/2008
9934Further bids for Elan unit due mid-Sept -sources By Megan Davies and Douwe Miesim1-9/5/2008
9933Elan announces start of trial with Tysabri in cancer indication. Interesting!Arthur Radley-9/5/2008
9932Pfizer and Medivation Enter into Global Agreement to Co-Develop and Market DimebQualified Opinion-9/3/2008
9931Elan's bapineuzumab could be highly synergistic with mtihtramycin and/or PEIgeorgejjl1-9/1/2008
9930<b>Mixed results for disease-modification strategies for Alzheimer’s diseaidos-9/1/2008
9929This comment at the end of the link you posted was of interest, I thought... &qArthur Radley-8/26/2008
9928edit: Old news, sorry. Headlines not followed by "new" news. <i&scaram(o)uche-8/26/2008
9927Biogen Idec shares gain on Tysabri outlook Associated Press 08.26.08, 11:40 AM Eclutterer-8/26/2008
9926It's all about the welfare of the patients. The stock price isn't importQualified Opinion-8/25/2008
9925Fido held and went down with the stock price. They're usually the ones who cQualified Opinion-8/25/2008
9924Will be interesting to hear the update tomorrow on the 2 patients that contract Arthur Radley-8/25/2008
9923It doesn't take much news to move the stock price. ELN isn't held back bQualified Opinion-8/25/2008
9922Good news...only added Black Box information...no plans to pull the drug by the Arthur Radley-8/25/2008
9921>>If you insist on calling me names, a scientist is a much better one. EvIRWIN JAMES FRANKEL-8/21/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News